🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07760727
Starting soon Observational

High-Flow Nasal Oxygyen Therapy During Sedated Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration(EBUS-TBNA)

NCT07760727 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-08-20
Last updated
2026-08-12

Condition(s) studied

High Flow Oxygen TherapyENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATIONSedationSedation ComplicationBlood Gas Analysis

Investigational drug(s) / intervention(s)

High-Flow Nasal Oxygen TherapyConventional Oxygen Therapy

High-Flow Nasal Oxygen Therapy: High-flow nasal oxygen therapy administered during sedated EBUS-TBNA procedures to provide enhanced oxygenation and respiratory support.

Conventional Oxygen Therapy: Conventional oxygen therapy administered during sedated EBUS-TBNA procedures using standard oxygen delivery methods

Study summary

This study aims to evaluate the effects of high-flow nasal oxygen therapy on respiratory complications, blood gas parameters, and post-procedural recovery in patients undergoing sedated endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Participants will be assigned to receive either high-flow nasal oxygen therapy or conventional oxygen therapy during the procedure. The incidence of respiratory complications, blood gas changes, and recovery outcomes will be compared between the two groups.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Age ≥18 years. Scheduled to undergo sedated EBUS-TBNA. Ability to provide written informed consent. ASA physical status I-III. Exclusion Criteria: * Age \<18 years. * Pregnancy. * Requirement for endotracheal intubation or general anesthesia. * Severe hemodynamic instability. * Refusal to participate in the study. * Contraindication to high-flow nasal oxygen therapy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara Dr. Abdurrahman Yurtaslan Oncolgy Training and Research Hospital Ankara Central

More Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07760727 on ClinicalTrials.gov ↗ ← All trials in Turkey